Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 Nov;66(2):443–449.

Imbalanced serum IgG subclass pattern in toxic shock syndrome patients: deficiency of specific IgG1 and IgG4 subclass antibodies to toxic shock syndrome toxin 1.

B Christensson, P J Johansson, V A Oxelius
PMCID: PMC1542541  PMID: 3815898

Abstract

An imbalanced serum IgG subclass pattern was identified in 10 patients with toxic shock syndrome (TSS) showing remarkably low subclass levels of various combinations. IgG2 levels were significantly reduced as compared to normal controls. The IgG subclass-specificity of antibodies to toxic shock syndrome toxin (TSST-1) was investigated by a solid-phase radioimmunoassay. TSS-patients lacked pre-immunity to TSST-1 in all four IgG subclasses. Normally acquired immunity to the toxin as well as the serological response developing in two patients with TSS was generally restricted to IgG1 and IgG4. A strong booster response of all four IgG subclasses was seen in three patients with S. aureus septicaemia due to TSST-1 producing strains. The lack of specific IgG1 and IgG4 antibodies to TSST-1 and the low serum IgG subclass levels found in the TSS-patients could be of pathogenetic significance and help to explain the susceptibility to TSS in certain individuals.

Full text

PDF
443

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergdoll M. S., Crass B. A., Reiser R. F., Robbins R. N., Davis J. P. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet. 1981 May 9;1(8228):1017–1021. doi: 10.1016/s0140-6736(81)92186-3. [DOI] [PubMed] [Google Scholar]
  2. Bergdoll M. S., Crass B. A., Reiser R. F., Robbins R. N., Lee A. C., Chesney P. J., Davis J. P., Vergeront J. M., Wand P. J. An enterotoxin-like protein in Staphylococcus aureus strains from patients with toxic shock syndrome. Ann Intern Med. 1982 Jun;96(6 Pt 2):969–971. doi: 10.7326/0003-4819-96-6-969. [DOI] [PubMed] [Google Scholar]
  3. Bonventre P. F., Linnemann C., Weckbach L. S., Staneck J. L., Buncher C. R., Vigdorth E., Ritz H., Archer D., Smith B. Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers. J Infect Dis. 1984 Nov;150(5):662–666. doi: 10.1093/infdis/150.5.662. [DOI] [PubMed] [Google Scholar]
  4. Bonventre P. F., Weckbach L., Staneck J., Schlievert P. M., Thompson M. Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources. Infect Immun. 1983 Jun;40(3):1023–1029. doi: 10.1128/iai.40.3.1023-1029.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chesney P. J., Bergdoll M. S., Davis J. P., Vergeront J. M. The disease spectrum, epidemiology, and etiology of toxic-shock syndrome. Annu Rev Microbiol. 1984;38:315–338. doi: 10.1146/annurev.mi.38.100184.001531. [DOI] [PubMed] [Google Scholar]
  6. Christensson B., Espersen F., Hedström S. A., Kronvall G. Serological assays against Staphylococcus aureus peptidoglycan, crude staphylococcal antigen and staphylolysin in the diagnosis of serious S. aureus infections. Scand J Infect Dis. 1985;17(1):47–53. doi: 10.3109/00365548509070419. [DOI] [PubMed] [Google Scholar]
  7. Christensson B., Hedström S. A. Biochemical and biological properties of Staphylococcus aureus septicemia strains in relation to clinical characteristics. Scand J Infect Dis. 1986;18(4):297–303. doi: 10.3109/00365548609032340. [DOI] [PubMed] [Google Scholar]
  8. Christensson B., Hedström S. A. Serological response to toxic shock syndrome toxin in Staphylococcus aureus infected patients and healthy controls. Acta Pathol Microbiol Immunol Scand B. 1985 Apr;93(2):87–90. doi: 10.1111/j.1699-0463.1985.tb02857.x. [DOI] [PubMed] [Google Scholar]
  9. Cohen M. L., Graves L. M., Hayes P. S., Gibson R. J., Rasheed J. K., Feeley J. C. Toxic shock syndrome: modification and comparison of methods for detecting marker proteins in Staphylococcus aureus. J Clin Microbiol. 1983 Aug;18(2):372–375. doi: 10.1128/jcm.18.2.372-375.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Davis J. P., Vergeront J. M., Chesney P. J. Possible host-defense mechanisms in toxic shock syndrome. Ann Intern Med. 1982 Jun;96(6 Pt 2):986–991. doi: 10.7326/0003-4819-96-6-986. [DOI] [PubMed] [Google Scholar]
  11. Hammarström L., Granström M., Oxelius V., Persson M. A., Smith C. I. IgG subclass distribution of antibodies against S. aureus teichoic acid and alpha-toxin in normal and immunodeficient donors. Clin Exp Immunol. 1984 Mar;55(3):593–601. [PMC free article] [PubMed] [Google Scholar]
  12. Hirose-Kumagai A., Whipple F. H., Ikejima T., Dinarello C. A., Gill D. M., Ritz H. L., Bond G. G. A comparison of neutralizing and antigen-binding assays for human antibodies against toxic-shock-syndrome toxin 1. J Infect Dis. 1984 Nov;150(5):788–788. doi: 10.1093/infdis/150.5.788. [DOI] [PubMed] [Google Scholar]
  13. Notermans S., van Leeuwen W. J., Dufrenne J., Tips P. D. Serum antibodies to enterotoxins produced by Staphylococcus aureus with special reference to enterotoxin F and toxic shock syndrome. J Clin Microbiol. 1983 Nov;18(5):1055–1060. doi: 10.1128/jcm.18.5.1055-1060.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Oxelius V. A. Crossed immunoelectrophoresis and electroimmunoassay of human IgG subclasses. Acta Pathol Microbiol Scand C. 1978 Jun;86C(3):109–116. doi: 10.1111/j.1699-0463.1978.tb02567.x. [DOI] [PubMed] [Google Scholar]
  15. Oxelius V. A. IgG subclass levels in infancy and childhood. Acta Paediatr Scand. 1979 Jan;68(1):23–27. doi: 10.1111/j.1651-2227.1979.tb04424.x. [DOI] [PubMed] [Google Scholar]
  16. Reiser R. F., Robbins R. N., Khoe G. P., Bergdoll M. S. Purification and some physicochemical properties of toxic-shock toxin. Biochemistry. 1983 Aug 2;22(16):3907–3912. doi: 10.1021/bi00285a028. [DOI] [PubMed] [Google Scholar]
  17. Schlievert P. M. Alteration of immune function by staphylococcal pyrogenic exotoxin type C: possible role in toxic-shock syndrome. J Infect Dis. 1983 Mar;147(3):391–398. doi: 10.1093/infdis/147.3.391. [DOI] [PubMed] [Google Scholar]
  18. Schlievert P. M., Shands K. N., Dan B. B., Schmid G. P., Nishimura R. D. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis. 1981 Apr;143(4):509–516. doi: 10.1093/infdis/143.4.509. [DOI] [PubMed] [Google Scholar]
  19. Shakib F., Stanworth D. R. Human IgG subclasses in health and disease. (A review). Part II. Ric Clin Lab. 1980 Oct-Dec;10(4):561–580. doi: 10.1007/BF02906696. [DOI] [PubMed] [Google Scholar]
  20. Stolz S. J., Davis J. P., Vergeront J. M., Crass B. A., Chesney P. J., Wand P. J., Bergdoll M. S. Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin. J Infect Dis. 1985 May;151(5):883–889. doi: 10.1093/infdis/151.5.883. [DOI] [PubMed] [Google Scholar]
  21. Thorell J. I., Johansson B. G. Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim Biophys Acta. 1971 Dec 28;251(3):363–369. doi: 10.1016/0005-2795(71)90123-1. [DOI] [PubMed] [Google Scholar]
  22. Todd J., Fishaut M., Kapral F., Welch T. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet. 1978 Nov 25;2(8100):1116–1118. doi: 10.1016/s0140-6736(78)92274-2. [DOI] [PubMed] [Google Scholar]
  23. Vergeront J. M., Stolz S. J., Crass B. A., Nelson D. B., Davis J. P., Bergdoll M. S. Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome. J Infect Dis. 1983 Oct;148(4):692–698. doi: 10.1093/infdis/148.4.692. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES